小密度的LDL:一个被低估的动脉样硬化的驱动因素 (评论)
Makhabbat Bekbossynova1, Timur Saliev2, Tatyana Ivanova-Razumova1
1Heart Center, University Medical Center, Nazarbayev University, Astana 010000, Kazakhstan.
Molecular medicine reports
|September 26, 2025
概括
小而密集的低密度脂蛋白 (sdLDL) 颗粒显著促进心血管疾病风险,特别是在代谢障碍中. 监测sdLDL对于更好的心血管风险评估和管理至关重要.
科学领域:
- 心脏病学 心脏病学
- 脂质学 脂质学是指脂质学.
- 预防医学 预防医学
背景情况:
- 心血管疾病是全球主要的死亡原因.
- 小而密集的低密度脂蛋白 (sdLDL) 颗粒具有高度的动脉毒性,有助于残留心血管风险.
- 升高的sdLDL常见于胰岛素耐药性,2型糖尿病和肥胖等代谢障碍.
研究的目的:
- 审查使 sdLDL 变得异质的病理生理机制.
- 探索sdLDL在内皮功能障碍,炎症和斑块不稳定中的作用.
- 讨论诊断挑战,临床相关性和目前sdLDL的脂质面板的局限性.
主要方法:
- 批判性地检查sdLDL的病理生理特征.
- 综述了将sdLDL与心血管事件联系起来的流行病学研究.
- 分析生活方式和药理策略,以减少SDLDL.
主要成果:
- sdLDL表现出增加的透性,延长的循环,以及增加的氧化易感性.
- sdLDL促进内皮功能障碍,泡细胞形成,炎症和斑块不稳定.
- 增加的sdLDL是心血管事件的独立预测因子,特别是在高风险人群中.
结论:
- sdLDL在动脉动脉发生和残留心血管风险方面发挥着重要作用.
- 目前的脂质面板通常无法捕捉sdLDL对疾病的贡献.
- 建议加强sdLDL测试和先进诊断,包括AI,以改善风险评估和管理.
相关概念视频
Inflammation
Overview
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...


